These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 38803477)
1. The association of body mass index variability with cardiovascular disease and mortality: a mediation analysis of pooled cohorts. Mehran L; Honarvar M; Masoumi S; Khalili D; Azizi F; Blaha MJ; Amouzegar A Front Endocrinol (Lausanne); 2024; 15():1345781. PubMed ID: 38803477 [TBL] [Abstract][Full Text] [Related]
2. Weight fluctuation, mortality, and cardiovascular disease in adults in 18 years of follow-up: Tehran Lipid and Glucose Study. Mehran L; Honarvar M; Masoumi S; Khalili D; Amouzegar A; Azizi F J Endocrinol Invest; 2023 Jan; 46(1):37-49. PubMed ID: 35921037 [TBL] [Abstract][Full Text] [Related]
3. Associations of Variability in Blood Pressure, Glucose and Cholesterol Concentrations, and Body Mass Index With Mortality and Cardiovascular Outcomes in the General Population. Kim MK; Han K; Park YM; Kwon HS; Kang G; Yoon KH; Lee SH Circulation; 2018 Dec; 138(23):2627-2637. PubMed ID: 30571256 [TBL] [Abstract][Full Text] [Related]
4. Fasting glucose variability in young adulthood and incident diabetes, cardiovascular disease and all-cause mortality. Bancks MP; Carson AP; Lewis CE; Gunderson EP; Reis JP; Schreiner PJ; Yano Y; Carnethon MR Diabetologia; 2019 Aug; 62(8):1366-1374. PubMed ID: 31115643 [TBL] [Abstract][Full Text] [Related]
5. Visit-to-Visit Variability of Fasting Plasma Glucose and the Risk of Cardiovascular Disease and All-Cause Mortality in the General Population. Wang A; Liu X; Xu J; Han X; Su Z; Chen S; Zhang N; Wu S; Wang Y; Wang Y J Am Heart Assoc; 2017 Nov; 6(12):. PubMed ID: 29187392 [TBL] [Abstract][Full Text] [Related]
6. Cardiovascular health metrics and all-cause and cardiovascular disease mortality among middle-aged men in Korea: the Seoul male cohort study. Kim JY; Ko YJ; Rhee CW; Park BJ; Kim DH; Bae JM; Shin MH; Lee MS; Li ZM; Ahn YO J Prev Med Public Health; 2013 Nov; 46(6):319-28. PubMed ID: 24349653 [TBL] [Abstract][Full Text] [Related]
7. The effect of obesity phenotype changes on cardiovascular outcomes in adults older than 40 years in the prospective cohort of the Tehran lipids and glucose study (TLGS): joint model of longitudinal and time-to-event data. Sedaghat Z; Khodakarim S; Sabour S; Valizadeh M; Barzin M; Nejadghaderi SA; Azizi F BMC Public Health; 2024 Apr; 24(1):1126. PubMed ID: 38654182 [TBL] [Abstract][Full Text] [Related]
8. Long-Term Body Mass Index Variability and Adverse Cardiovascular Outcomes. Almuwaqqat Z; Hui Q; Liu C; Zhou JJ; Voight BF; Ho YL; Posner DC; Vassy JL; Gaziano JM; Cho K; Wilson PWF; Sun YV JAMA Netw Open; 2024 Mar; 7(3):e243062. PubMed ID: 38512255 [TBL] [Abstract][Full Text] [Related]
9. Medications for blood pressure, blood glucose, lipids, and anti-thrombotic medications: relationship with cardiovascular disease and death in adults from 21 high-, middle-, and low-income countries with an elevated body mass index. Leong DP; Rangarajan S; Rosengren A; Oguz A; Alhabib KF; Poirier P; Diaz R; Dans AL; Iqbal R; Yusufali AM; Yeates K; Chifamba J; Seron P; Lopez-Lopez J; Bahonar A; Wei L; Bo H; Weida L; Avezum A; Gupta R; Mohan V; Kruger HS; Lakshmi PVM; Yusuf R; Yusuf S Eur J Prev Cardiol; 2022 Oct; 29(14):1817-1826. PubMed ID: 35512128 [TBL] [Abstract][Full Text] [Related]
10. Triglyceride glucose-body mass index and cardiovascular mortality in patients undergoing peritoneal dialysis: a retrospective cohort study. Zhan C; Peng Y; Ye H; Diao X; Yi C; Guo Q; Chen W; Yang X Lipids Health Dis; 2023 Sep; 22(1):143. PubMed ID: 37670344 [TBL] [Abstract][Full Text] [Related]
11. Trajectories of body mass index before the diagnosis of cardiovascular disease: a latent class trajectory analysis. Dhana K; van Rosmalen J; Vistisen D; Ikram MA; Hofman A; Franco OH; Kavousi M Eur J Epidemiol; 2016 Jun; 31(6):583-92. PubMed ID: 26955830 [TBL] [Abstract][Full Text] [Related]
12. Changes in Fasting plasma glucose status and risk of mortality events in individuals without diabetes over two decades of Follow-up: a pooled cohort analysis. Kohansal K; Masrouri S; Khalili D; Ramezankhani A; Azizi F; Blaha MJ; Hadaegh F Cardiovasc Diabetol; 2022 Dec; 21(1):267. PubMed ID: 36463152 [TBL] [Abstract][Full Text] [Related]
13. Association of carotid atherosclerosis markers with all-cause and cardiovascular disease-specific mortality in persons with type 2 diabetes: a causal mediation analysis with glucose variation. Lin CC; Li CI; Liu CS; Lin CH; Yang SY; Li TC Acta Diabetol; 2024 May; 61(5):657-669. PubMed ID: 38393346 [TBL] [Abstract][Full Text] [Related]
14. Association of Body Mass Index With Lifetime Risk of Cardiovascular Disease and Compression of Morbidity. Khan SS; Ning H; Wilkins JT; Allen N; Carnethon M; Berry JD; Sweis RN; Lloyd-Jones DM JAMA Cardiol; 2018 Apr; 3(4):280-287. PubMed ID: 29490333 [TBL] [Abstract][Full Text] [Related]
16. Serum fructosamine and risk of cardiovascular and all-cause mortality: a 24-year prospective population-based study. Zaccardi F; Kurl S; Pitocco D; Ronkainen K; Laukkanen JA Nutr Metab Cardiovasc Dis; 2015 Feb; 25(2):236-41. PubMed ID: 25445881 [TBL] [Abstract][Full Text] [Related]
17. The association between fasting plasma glucose variability and incident eGFR decline: evidence from two cohort studies. Deravi N; Sharifi Y; Koohi F; Zadeh SST; Masrouri S; Azizi F; Hadaegh F BMC Public Health; 2023 Mar; 23(1):565. PubMed ID: 36973769 [TBL] [Abstract][Full Text] [Related]
18. High triglyceride-glucose index in young adulthood is associated with incident cardiovascular disease and mortality in later life: insight from the CARDIA study. Xu X; Huang R; Lin Y; Guo Y; Xiong Z; Zhong X; Ye X; Li M; Zhuang X; Liao X Cardiovasc Diabetol; 2022 Aug; 21(1):155. PubMed ID: 35962377 [TBL] [Abstract][Full Text] [Related]
19. Development, characterization, and replication of proteomic aging clocks: Analysis of 2 population-based cohorts. Wang S; Rao Z; Cao R; Blaes AH; Coresh J; Deo R; Dubin R; Joshu CE; Lehallier B; Lutsey PL; Pankow JS; Post WS; Rotter JI; Sedaghat S; Tang W; Thyagarajan B; Walker KA; Ganz P; Platz EA; Guan W; Prizment A PLoS Med; 2024 Sep; 21(9):e1004464. PubMed ID: 39316596 [TBL] [Abstract][Full Text] [Related]
20. Does body mass index impact on the relationship between systolic blood pressure and cardiovascular disease?: meta-analysis of 419 488 individuals from the Asia pacific cohort studies collaboration. Tsukinoki R; Murakami Y; Huxley R; Ohkubo T; Fang X; Suh I; Ueshima H; Lam TH; Woodward M; Stroke; 2012 Jun; 43(6):1478-83. PubMed ID: 22426316 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]